All the President's Trade Negotiators - Revolving Doors, Regulatory Capture, and Health Care Corporate Friendly Trade Agreements

AbbeVie Abbott anechoic effect corporatism Eli Lilly global health health care prices Pfizer PhRMA regulatory capture revolving doors US Trade Representative

All the President's Trade Negotiators - Revolving Doors, Regulatory Capture, and Health Care Corporate Friendly Trade Agreements

Unknown 5/14/2015 Komentar

This week's spectacle in Washington, DC was a nearly unanimous Democratic minority in the Senate blocking a proposal for expedited consideration of multinational trade agreements favored by the Republican majority, but also...

Baca selengkapnya

As the Hepatitis C Marketing Frenzy Continues, a Reminder Not to Ignore the Evidence

AbbeVie clinical trials evidence-based medicine Gilead marketing Sovaldi

As the Hepatitis C Marketing Frenzy Continues, a Reminder Not to Ignore the Evidence

Unknown 1/05/2015 Komentar

The Hepatitis C Spin Cycle Continues Since our last post in July, 2014, about sofosbuvir (Sovaldi, Gilead), the $1000 pill proclaimed to be a wonder drug for the treatment of hepatitis C, the marketing juggernaut for new...

Baca selengkapnya